145 related articles for article (PubMed ID: 37691139)
1. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis spectrum disorders.
Irwin T; Yeung CCS; Shinohara MM
J Cutan Pathol; 2024 Jan; 51(1):76-82. PubMed ID: 37691139
[TBL] [Abstract][Full Text] [Related]
2. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
Hosaka H; Ohtoshi S; Nakada T; Iijima M
J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
[TBL] [Abstract][Full Text] [Related]
3. Pattern-Specific Loss of Desmoplakin I and II Immunoreactivity in Erythema Multiforme and its Variants: A Possible Aid in Histologic Diagnosis.
Forrester VJ; Tran B; Hein SC; Wick MR
Am J Dermatopathol; 2020 Feb; 42(2):111-116. PubMed ID: 31599750
[TBL] [Abstract][Full Text] [Related]
4. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
6. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
Yager JA
Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284
[TBL] [Abstract][Full Text] [Related]
7. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
[TBL] [Abstract][Full Text] [Related]
8. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
[TBL] [Abstract][Full Text] [Related]
9. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
Niemeijer IC; van Praag MC; van Gemund N
Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
[TBL] [Abstract][Full Text] [Related]
10. Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon?
Cozzani E; Di Zenzo G; Calabresi V; Caproni M; Schena D; Quaglino P; Marzano AV; Fabbri P; Rebora A; Parodi A
Eur J Dermatol; 2011; 21(1):32-6. PubMed ID: 21233064
[TBL] [Abstract][Full Text] [Related]
11. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
12. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
13. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
Su JR; Haber P; Ng CS; Marquez PL; Dores GM; Perez-Vilar S; Cano MV
Vaccine; 2020 Feb; 38(7):1746-1752. PubMed ID: 31870573
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Marzano AV; Frezzolini A; Caproni M; Parodi A; Fanoni D; Quaglino P; Girgenti V; La Placa M; Fabbri P; Caputo R; Berti E
Int J Immunopathol Pharmacol; 2007; 20(3):557-66. PubMed ID: 17880768
[TBL] [Abstract][Full Text] [Related]
15. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Monnose-Binding Lectin gene Polymorphism in Patients with Erythema Multiforme, Stevens-Johnson Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Syndrome.
Karkucak M; Bülbül EB; Turan H; Yakut T; Toka S; Sarıcaoğlu H
Balkan Med J; 2012 Sep; 29(3):310-3. PubMed ID: 25207021
[TBL] [Abstract][Full Text] [Related]
18. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 polymorphism in patients with erythema multiforme, Stevens Johnson syndrome and Stevens Johnson syndrome/toxic epidermal necrolysis overlap syndrome.
Turan H; Bulbul Baskan E; Yakut T; Karkucak M; Tunali S; Saricaoglu H
Bratisl Lek Listy; 2011; 112(5):260-3. PubMed ID: 21682079
[TBL] [Abstract][Full Text] [Related]
20. Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
Grünwald P; Mockenhaupt M; Panzer R; Emmert S
J Dtsch Dermatol Ges; 2020 Jun; 18(6):547-553. PubMed ID: 32469468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
